Johnson & Johnson to buy Japanese skin care holding company

By Deanna Utroske

- Last updated on GMT

Johnson & Johnson to buy Japanese skin care holding company
In a forward-looking statement issued late last month, the consumer packaged goods and pharmaceutical company announced an offer to acquire Ci:z Holdings Co., Ltd., which owns the Dr.Ci:Labo, Labo Labo, and Genomer skin care brands as well as some salon businesses and a valuable ecommerce management database.

The deal is being positioned as a move to improve J&J’s standing in Japan, in Japanese beauty, and in dermocosmetics, more broadly.

“Health and beauty consumers are actively seeking science-based innovation to improve their skin,”​ asserts Jorge Mesquita, worldwide chairman of Johnson & Johnson Consumer, in a press item posted on the company site. “This transaction,”​ he says, “will maximise value creation for Johnson & Johnson’s Consumer business by bringing in an agile innovation model and rapidly accelerating sales through our global commercialization expertise.”

And, the Ci:z “skincare portfolio is expected to strengthen Johnson & Johnson’s market presence in Japan with key customers, and more broadly bolster its offering in science-based, efficacious dermocosmetic brands,” ​according to the J&J press item.

Dollars and details

The Ci:z board issued a formal opinion on the offer the same day that J&J announced its plans publically. The holding company’s board of directors met and agreed to “support of the tender offer for its common shares to be conducted by Johnson & Johnson,”​ according to the opinion.

Proposed terms for the acquisition are ¥5,900 per share, or approximately ¥230 bn. And the deal is expected to be complete in Q1 of 2019.

Bigger picture

J&J outlines the key benefits of the deal in their press item; it will, of course, add value for shareholders.

The acquisition is also expected to strengthen the J&J consumer business (which is the division where its personal care brands operate).

And, there is an ecommerce win here for J&J. “The transaction will be a springboard to build Johnson & Johnson Consumer’s connected commerce capabilities by leveraging one of the largest customer relationship management databases for direct-to-consumer skincare in Japan,” ​according the company press item.

And J&J’s innovation and distribution networks will be leveraged to grow the acquired skin care brands.



Deanna Utroske, Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.

Related news

Show more

Related products

show more

Exosomes: Passing Trend or Transformative Reality?

Exosomes: Passing Trend or Transformative Reality?

Content provided by Naolys | 26-Mar-2024 | White Paper

Exosomes, microscopic vesicles naturally present in abundance within Plant Cells, have garnered significant attention within the scientific and cosmetic...

How Nutricosmetics Can Enhance Skin Beauty

How Nutricosmetics Can Enhance Skin Beauty

Content provided by Activ'Inside | 11-Dec-2023 | White Paper

In the ever-evolving realm of nutricosmetics, where inner wellness meets outer beauty, few natural ingredients have captured the spotlight quite like grapes.

Ultimate Antimicrobial Solution for BPC

Ultimate Antimicrobial Solution for BPC

Content provided by Acme-Hardesty Company | 11-Oct-2023 | White Paper

Sharomix™ EG10, a versatile broad-spectrum antimicrobial liquid blend for preserving personal care products, ensures safety at usage levels ranging from...

Acme-Hardesty Expands Product Line into Canada

Acme-Hardesty Expands Product Line into Canada

Content provided by Acme-Hardesty Company | 07-Jul-2023 | Product Brochure

Acme-Hardesty’s latest expansion into Canada includes Resplanta®, Botaneco®, and BYK from our partners Sharon Personal Care and Eckart Effect Pigments...

Related suppliers